Beersheba, Israel

Marina Shevachman

This inventor holds 6 USPTO granted patents. Top assignees: Perrigo Israel Pharmaceuticals Ltd., Sol-Gel Technologies Ltd.. Active years: 2014-2026.


% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2014-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Marina Shevachman

Introduction

Marina Shevachman is a notable inventor based in Beer-Sheva, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of topical compositions. With a total of five patents to her name, her work focuses on improving the efficacy and safety of pharmaceutical products.

Latest Patents

One of her latest patents involves pharmaceutical compositions comprising silica microspheres. These topical vaginal compositions include silica microspheres and an active ingredient selected from estradiol, metronidazole, clindamycin, butoconazole, and combinations thereof. The formulations are designed to provide sustained release of the active ingredient, thereby reducing skin irritation. This innovative approach enhances the therapeutic effects while minimizing adverse reactions.

Career Highlights

Throughout her career, Marina has worked with prominent companies in the pharmaceutical industry. Notable among these are Sol-Gel Technologies Ltd. and Perrigo Israel Pharmaceuticals Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking advancements in pharmaceutical technology.

Collaborations

Marina has collaborated with several professionals in her field, including Eilon Asculai and Nir Avram. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Marina Shevachman is a pioneering inventor whose work in pharmaceutical compositions has the potential to significantly impact patient care. Her dedication to innovation and collaboration continues to drive advancements in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…